Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.67 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.50 |
| ▸ | ESR1 | P03372 | 2/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.49 |
| ▸ | ALPI | P09923 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | XIAP | P98170 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4453960 | 1.00 | SLC7A5 (0.67) | SLC7A5TAAR1SLC6A2HDAC8ESR1 | |
| SCHEMBL27858201 | 0.93 | SLC7A5 (0.59) | SLC7A5TAAR1SLC6A2HDAC8ESR1 | |
| SCHEMBL1422055 | 0.93 | SLC7A5 (0.64) | SLC7A5HDAC8ALPIPKMPTGS1 | |
| SCHEMBL27858204 | 0.93 | SLC7A5 (0.59) | SLC7A5TAAR1SLC6A2HDAC8ESR1 | |
| SCHEMBL28698329 | 0.93 | SLC7A5 (0.62) | SLC7A5TAAR1SLC6A2HDAC8ESR1 | |
| SCHEMBL28698332 | 0.93 | SLC7A5 (0.62) | SLC7A5TAAR1SLC6A2HDAC8ESR1 | |
| SCHEMBL2490445 | 0.92 | SLC7A5 (0.57) | SLC7A5TAAR1SLC6A2HDAC8ESR1 | |
| SCHEMBL5707698 | 0.92 | SLC7A5 (0.57) | SLC7A5TAAR1SLC6A2HDAC8ESR1 | |
| SCHEMBL321221 | 0.91 | SLC7A5 (0.61) | SLC7A5TAAR1SLC6A2HDAC8ESR1 | |
| SCHEMBL4279625 | 0.91 | SLC7A5 (0.61) | SLC7A5TAAR1SLC6A2HDAC8ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119909240-A | Pharmaceutical composition, drug-loaded device and therapeutic system for forming enhanced in situ vascular stents | 杭州矩正医疗科技有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-101044188-A | Process for preparing glatiramer | SANDOZ AG (CH) | 2007-09-26 | — | — | CN | disclosed |